US 11376247
Tyrosine kinase inhibitors regenerate non-cancerous tissue after cancer therapy
granted A61KA61K31/4025A61K31/496
Quick answer
US patent 11376247 (Tyrosine kinase inhibitors regenerate non-cancerous tissue after cancer therapy) held by The Regents of the University of Colorado, a Body Corporate expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/4025, A61K31/496, A61K31/5025, A61K31/506